Lymphoma in 2022
hosted byHorizon CMELymphoma in 2022 is organized by Horizon CME.
Course opens: 03/15/2023
Course expires: 03/15/2024
Description:
The importance for clinicians to accurately work-up, assess, and classify lymphoma is fundamental for the optimization of patients’ oncology treatment journey. This webcast will walk participants through treatment regimens for various types of lymphoma, including standard chemotherapy regimens as well as novel therapies such as CAR T-cell therapies and not yet FDA-approved combinations.
Learning Objectives:
List the general classification of lymphoma
Describe the treatment of advanced stage classical Hodgkin lymphoma with A+AVD chemotherapy regimen
Discuss Pola-R-CHP regimen as an upcoming novel treatment option in diffuse large B cell lymphoma (not yet FDA approved combination)
Recognize chimeric antigen receptor Tcell therapy (CAR-T) and its use in non-Hodgkin lymphoma
Additional details will be posted as soon as information is available
